Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method
- PMID: 11307626
- DOI: 10.1007/s004010000293
Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method
Abstract
A graph method was employed to analyze the spatial neuronal patterns of nuclear grays of the pontine tegmentum with ascending aminergic projections to the forebrain in 12 cases of frontotemporal dementia (FTD). The nuclear grays examined were the nucleus centralis superior (NCS), a part of the nucleus raphae dorsalis (NRD), and the locus coeruleus (LC). The results were compared with 30 cases of Alzheimer's disease (AD) and 35 non-demented controls. In addition to the graph evaluations, neuronal cytoplasmic inclusion bodies were stained by silver impregnation and ubiquitin (Ub) and tau immunohistochemistry. The FTD cases showed a significant, 40%, decline in number of neurons in the NCS and NRD, while the LC was spared. The magnitude of neuronal loss matched that of AD where, by contrast, the LC was also severely changed. Amyloid deposition and Alzheimer neurofibrillary tangles occurred in the aminergic nuclei almost exclusively in AD and, to a minor extent, in some aged controls. No cytoplasmic inclusion bodies were found in the aminergic nuclei of the FTD cases. However, 6 cases had Ub-positive but tau-negative neuronal inclusions in the hippocampal dentate fascia and in layer 2 of the prefrontal isocortex, and 3 showed clinical and histological signs of motor neuron disease. Our results suggest that the serotoninergic raphe nuclei with ascending projections to the forebrain, but not the LC, become directly or indirectly involved in frontotemporal dementia both with and without motor neuron disease.
Similar articles
-
Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary neurodegenerative and vascular dementia: a comparative immunocytochemical and quantitative study using a graph method.Anal Cell Pathol. 1999;19(3-4):125-38. doi: 10.1155/1999/256382. Anal Cell Pathol. 1999. PMID: 10866275 Free PMC article.
-
Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.Acta Neuropathol. 2002 Jun;103(6):599-606. doi: 10.1007/s00401-001-0509-1. Epub 2002 Feb 21. Acta Neuropathol. 2002. PMID: 12012092
-
Motor neurone disease-inclusion dementia.Neurodegeneration. 1996 Dec;5(4):339-50. doi: 10.1006/neur.1996.0046. Neurodegeneration. 1996. PMID: 9117546
-
The new neuropathology of degenerative frontotemporal dementias.Acta Neuropathol. 1996;91(2):127-34. doi: 10.1007/s004010050403. Acta Neuropathol. 1996. PMID: 8787144 Review.
-
Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24. Neurosci Biobehav Rev. 2013. PMID: 23707776 Review.
Cited by
-
Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia.Brain Commun. 2021 Jul 16;3(3):fcab158. doi: 10.1093/braincomms/fcab158. eCollection 2021. Brain Commun. 2021. PMID: 34458729 Free PMC article. Review.
-
Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease.Springerplus. 2015 Jan 17;4:25. doi: 10.1186/s40064-014-0777-6. eCollection 2015. Springerplus. 2015. PMID: 25635245 Free PMC article.
-
Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy.Neuroimage Clin. 2013;2:459-468. doi: 10.1016/j.nicl.2013.03.009. Neuroimage Clin. 2013. PMID: 23853762 Free PMC article.
-
Improving response inhibition systems in frontotemporal dementia with citalopram.Brain. 2015 Jul;138(Pt 7):1961-75. doi: 10.1093/brain/awv133. Epub 2015 May 21. Brain. 2015. PMID: 26001387 Free PMC article. Clinical Trial.
-
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.Psychopharmacology (Berl). 2008 Mar;196(4):603-10. doi: 10.1007/s00213-007-0992-8. Epub 2007 Nov 18. Psychopharmacology (Berl). 2008. PMID: 18026720
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical